Search research articles
Contact Us
Filters
Showing results (31-40 of 72) with videos related to
Page
of 8
Sort By:
Human Molecular Genetics
|
February 8, 2017
Metformin pharmacogenomics: a genome-wide association study to identify genetic and epigenetic biomarkers involved in metformin anticancer response using human lymphoblastoid cell lines
Nifang Niu, Tongzheng Liu, Junmei Cairns, et al.
European Journal of Heart Failure
|
June 23, 2025
Significance of common genetic variants associated with non-ischaemic cardiomyopathy in the general population
Alessia Paldino, Marta Figueiral, Hridyanshu Vyas, et al.
International Journal of Bipolar Disorders
|
December 8, 2025
Antipsychotic use in bipolar disorder: clinical and genomic correlates- a Mayo clinic bipolar disorder biobank study
Balwinder Singh, Ada Man-Choi Ho, Brandon J Coombes, et al.
Cancer Research
|
April 1, 2010
Variation in anastrozole metabolism and pharmacodynamics in women with early breast cancer
James N Ingle, Aman U Buzdar, Daniel J Schaid, et al.
Molecular Endocrinology (Baltimore, Md.)
|
August 23, 2014
Aromatase inhibitor-associated bone fractures: a case-cohort GWAS and functional genomics
Mohan Liu, Paul E Goss, James N Ingle, et al.
Pharmacogenetics and Genomics
|
February 11, 2012
Merging pharmacometabolomics with pharmacogenomics using '1000 Genomes' single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics
Ryan Abo, Scott Hebbring, Yuan Ji, et al.
Research Square
|
August 13, 2025
Antipsychotic Use in Bipolar Disorder: Clinical and Genomic Correlates- A Mayo Clinic Bipolar Disorder Biobank Study
Balwinder Singh, Ada Man-Choi Ho, Brandon J Coombes, et al.
Cancer Research
|
January 6, 2010
Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors
Liewei Wang, Katarzyna A Ellsworth, Irene Moon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 2, 2011
Evaluation of CYP2D6 and efficacy of tamoxifen and raloxifene in women treated for breast cancer chemoprevention: results from the NSABP P1 and P2 clinical trials
Matthew P Goetz, Daniel J Schaid, D Lawrence Wickerham, et al.
Brain Communications
|
January 11, 2021
Variants in <i>PPP2R2B</i> and <i>IGF2BP3</i> are associated with higher tau deposition
Vijay K Ramanan, Xuewei Wang, Scott A Przybelski, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 72) with videos related to
Sort By:
Page
of 8
Human Molecular Genetics
|
February 8, 2017
Metformin pharmacogenomics: a genome-wide association study to identify genetic and epigenetic biomarkers involved in metformin anticancer response using human lymphoblastoid cell lines
Nifang Niu, Tongzheng Liu, Junmei Cairns, et al.
European Journal of Heart Failure
|
June 23, 2025
Significance of common genetic variants associated with non-ischaemic cardiomyopathy in the general population
Alessia Paldino, Marta Figueiral, Hridyanshu Vyas, et al.
International Journal of Bipolar Disorders
|
December 8, 2025
Antipsychotic use in bipolar disorder: clinical and genomic correlates- a Mayo clinic bipolar disorder biobank study
Balwinder Singh, Ada Man-Choi Ho, Brandon J Coombes, et al.
Cancer Research
|
April 1, 2010
Variation in anastrozole metabolism and pharmacodynamics in women with early breast cancer
James N Ingle, Aman U Buzdar, Daniel J Schaid, et al.
Molecular Endocrinology (Baltimore, Md.)
|
August 23, 2014
Aromatase inhibitor-associated bone fractures: a case-cohort GWAS and functional genomics
Mohan Liu, Paul E Goss, James N Ingle, et al.
Pharmacogenetics and Genomics
|
February 11, 2012
Merging pharmacometabolomics with pharmacogenomics using '1000 Genomes' single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics
Ryan Abo, Scott Hebbring, Yuan Ji, et al.
Research Square
|
August 13, 2025
Antipsychotic Use in Bipolar Disorder: Clinical and Genomic Correlates- A Mayo Clinic Bipolar Disorder Biobank Study
Balwinder Singh, Ada Man-Choi Ho, Brandon J Coombes, et al.
Cancer Research
|
January 6, 2010
Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors
Liewei Wang, Katarzyna A Ellsworth, Irene Moon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 2, 2011
Evaluation of CYP2D6 and efficacy of tamoxifen and raloxifene in women treated for breast cancer chemoprevention: results from the NSABP P1 and P2 clinical trials
Matthew P Goetz, Daniel J Schaid, D Lawrence Wickerham, et al.
Brain Communications
|
January 11, 2021
Variants in <i>PPP2R2B</i> and <i>IGF2BP3</i> are associated with higher tau deposition
Vijay K Ramanan, Xuewei Wang, Scott A Przybelski, et al.
Page
of 8